LifeMD (LFMD) Preferred Stock Liabilities (2020 - 2023)

LifeMD's Preferred Stock Liabilities history runs 4 years deep, the most recent figure standing at $5.0 million for Q2 2023.

• Quarterly Preferred Stock Liabilities rose 16.06% year-over-year to $5.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $5.0 million (up 16.06% YoY) and the FY2022 annual result came in at $4.6 million, up 11.07% from the prior year.
• Preferred Stock Liabilities was $5.0 million for Q2 2023 at LifeMD, up from $4.7 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $5.0 million in Q2 2023 and bottomed at $3.7 million in Q4 2020.
• A 4-year average of $4.2 million and a median of $4.2 million in 2022 frame the typical range for Preferred Stock Liabilities.
• Peak annual rise in Preferred Stock Liabilities reached 16.06% in 2023, while the deepest fall reached 10.77% in 2023.
• LifeMD's Preferred Stock Liabilities stood at $3.7 million in 2020, then grew by 12.45% to $4.1 million in 2021, then gained by 11.07% to $4.6 million in 2022, then advanced by 10.23% to $5.0 million in 2023.
• Business Quant data shows LFMD's Preferred Stock Liabilities at $5.0 million in Q2 2023, $4.7 million in Q1 2023, and $4.6 million in Q4 2022.